Top

Graefe's Archive for Clinical and Experimental Ophthalmology

Published in:

Open Access 01-05-2019 | Glaucoma | Glaucoma

Two-year results of a multicenter study of the ab interno gelatin implant in medically uncontrolled primary open-angle glaucoma

Authors: Herbert Reitsamer, Chelvin Sng, Vanessa Vera, Markus Lenzhofer, Keith Barton, Ingeborg Stalmans, For The Apex Study Group

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 5/2019

Abstract

Purpose

To evaluate the effectiveness of an ab interno subconjunctival gelatin implant as primary surgical intervention in reducing intraocular pressure (IOP) and IOP-lowering medication count in medically uncontrolled moderate primary open-angle glaucoma (POAG).

Methods

In this prospective, non-randomized, open-label, multicenter, 2-year study, eyes with medicated baseline IOP 18–33 mmHg on 1–4 topical medications were implanted with (phaco + implant) or without (implant alone) phacoemulsification. Changes in mean IOP and medication count at months 12 (primary outcomes) and 24, clinical success rate (eyes [%] achieving ≥ 20% IOP reduction from baseline on the same or fewer medications without glaucoma-related secondary surgical intervention), intraoperative complications, and postoperative adverse events were assessed.

Results

The modified intent-to-treat population included 202 eyes (of 218 implanted). Changes (standard deviation) in mean IOP and medication count from baseline were − 6.5 (5.3) mmHg and − 1.7 (1.3) at month 12 and − 6.2 (4.9) mmHg and − 1.5 (1.4) at month 24, respectively (all P < 0.001). Mean medicated baseline IOP was reduced from 21.4 (3.6) to 14.9 (4.5) mmHg at 12 months and 15.2 (4.2) mmHg at 24 months, with similar results in both treatment groups. The clinical success rate was 67.6% at 12 months and 65.8% at 24 months. Overall, 51.1 (12 months) and 44.7% (24 months) of eyes were medication-free. The implant safety profile compared favorably with that published for trabeculectomy and tube shunts.

Conclusions

The gelatin implant effectively reduced IOP and medication needs over 2 years in POAG uncontrolled medically, with an acceptable safety profile.

ClinicalTrials.gov registration number: NCT02006693 (registered in the USA).

American Academy of Ophthalmology (2015) Primary open-angle glaucoma—preferred practice pattern. http://www.aaojournal.org/article/S0161-6420(15)01276-2/pdf. Accessed January 23, 2018

European Glaucoma Society Terminology and guidelines for glaucoma (4th edition). https://www.eugs.org/eng/guidelines.asp. Accessed January 23, 2018

Lichter PR, Musch DC, Gillespie BW, Guire KE, Janz NK, Wren PA, Mills RP, CIGTS Study Group (2001) Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology 108:1943–1953. https://doi.org/10.1016/S0161-6420(01)00873-9 CrossRefPubMed

Feiner L, Piltz-Seymour JR (2003) Collaborative Initial Glaucoma Treatment Study: a summary of results to date. Curr Opin Ophthalmol 14:106–111CrossRefPubMed

Jampel HD, Musch DC, Gillespie BW, Lichter PR, Wright MM, Guire KE (2005) Perioperative complications of trabeculectomy in the collaborative initial glaucoma treatment study (CIGTS). Am J Ophthalmol 140:16–22. https://doi.org/10.1016/j.ajo.2005.02.013 CrossRefPubMed

Zahid S, Musch DC, Niziol LM, Lichter PR (2013) Risk of endophthalmitis and other long-term complications of trabeculectomy in the Collaborative Initial Glaucoma Treatment Study (CIGTS). Am J Ophthalmol 155:674–680.e1. https://doi.org/10.1016/j.ajo.2012.10.017 CrossRefPubMed

Gedde SJ, Feuer WJ, Shi W, Lim KS, Barton K, Goyal S, Ahmed IIK, Brandt J (2018) Treatment outcomes in the primary tube versus trabeculectomy study after 1 year of follow-up. Ophthalmology 125:650–663. https://doi.org/10.1016/j.ophtha.2018.02.003 CrossRefPubMed

Vera VI, Horvath C (2014) XEN gel stent: the solution designed by AqueSys®. In: Samples JR, Ahmed IIK (eds) Surgical innovations in glaucoma. Springer Science+Business Media, New York, pp 189–198CrossRef

Samuelson TW, Katz LJ, Wells JM, Duh YJ, Giamporcaro JE (2011) Randomized evaluation of the trabecular micro-bypass stent with phacoemulsification in patients with glaucoma and cataract. Ophthalmology 118:459–467. https://doi.org/10.1016/j.ophtha.2010.07.007 CrossRefPubMed

10.

Vold S, Ahmed IIK, Craven ER, Mattox C, Stamper R, Packer M, Brown RH, Ianchulev T (2016) Two-year COMPASS trial results: supraciliary microstenting with phacoemulsification in patients with open-angle glaucoma and cataracts. Ophthalmology 123:2103–2112. https://doi.org/10.1016/j.ophtha.2016.06.032 CrossRefPubMed

11.

Caprioli J, Kim JH, Friedman DS, Kiang T, Moster MR, Parrish RK 2nd, Rorer EM, Samuelson T, Tarver ME, Singh K, Eydelman MB (2015) Special commentary: supporting innovation for safe and effective minimally invasive glaucoma surgery: summary of a joint meeting of the American Glaucoma Society and the Food and Drug Administration, Washington, DC, February 26, 2014. Ophthalmology 122:1795–1801. https://doi.org/10.1016/j.ophtha.2015.02.029 CrossRefPubMed

12.

De Gregorio A, Pedrotti E, Russo L, Morselli S (2017) Minimally invasive combined glaucoma and cataract surgery: clinical results of the smallest ab interno gel stent. Int Ophthalmol 38:1129–1134. https://doi.org/10.1007/s10792-017-0571-x

13.

Galal A, Bilgic A, Eltanamly R, Osman A (2017) XEN glaucoma implant with mitomycin C 1-year follow-up: result and complications. J Ophthalmol 2017:5457246. https://doi.org/10.1155/2017/5457246 CrossRefPubMedPubMedCentral

14.

Hengerer FH, Kohnen T, Mueller M, Conrad-Hengerer I (2017) Ab interno gel implant for the treatment of glaucoma patients with or without prior glaucoma surgery: 1-year results. J Glaucoma 26:1130–1136. https://doi.org/10.1097/ijg.0000000000000803 CrossRefPubMed

15.

Sng CC, Wang J, Hau S, Htoon HM, Barton K (2017) XEN-45 collagen implant for the treatment of uveitic glaucoma. Clin Exp Ophthalmol 46:339–34. https://doi.org/10.1111/ceo.13087

16.

Mansouri K, Guidotti J, Rao HL, Ouabas A, D'Alessandro E, Roy S, Mermoud A (2018) Prospective evaluation of standalone XEN gel implant and combined phacoemulsification-XEN Gel implant surgery: 1-year results. J Glaucoma 27:140–147. https://doi.org/10.1097/IJG.0000000000000858 CrossRefPubMed

17.

Tan SZ, Walkden A, Au L (2018) One-year result of XEN45 implant for glaucoma: efficacy, safety, and postoperative management. Eye 32:324–332. https://doi.org/10.1038/eye.2017.162 CrossRefPubMed

18.

Ibáñez-Muñoz A, Soto-Biforcos VS, Chacón-González M, Rúa-Galisteo O, Arrieta-Los Santos A, Lizuain-Abadia ME, Del Río Mayor JL (2018) One-year follow-up of the XEN(R) implant with mitomycin-C in pseudoexfoliative glaucoma patients. Eur J Ophthalmol. https://doi.org/10.1177/1120672118795063

19.

Mansouri K, Gillmann K, Rao HL, Guidotti J, Mermoud A (2018) Prospective evaluation of XEN gel implant in eyes with pseudoexfoliative glaucoma. J Glaucoma 27:869–873. https://doi.org/10.1097/ijg.0000000000001045

20.

Parrish RK 2nd, Minckler DS, Lam D, Pfeiffer N, RojanaPongpun P (2009) Recommended methodology for glaucoma surgical trials. In: Shaarawy TM, Sherwood MB, Grehn F (eds) World Glaucoma Association Guidelines on design and reporting of glaucoma surgical trials. Kugler Publications, Amsterdam, pp 1–14

21.

Armstrong RA (2013) Statistical guidelines for the analysis of data obtained from one or both eyes. Ophthalmic Physiol Opt 33:7–14. https://doi.org/10.1111/opo.12009 CrossRefPubMed

22.

Rosner B, Glynn RJ, Lee ML (2003) Incorporation of clustering effects for the Wilcoxon rank sum test: a large-sample approach. Biometrics 59:1089–1098. https://doi.org/10.1111/j.0006-341X.2003.00125.x CrossRefPubMed

23.

Grover DS, Flynn WJ, Bashford KP, Lewis RA, Duh YJ, Nangia RS, Niksch B (2017) Performance and safety of a new ab interno gelatin stent in refractory glaucoma at 12 months. Am J Ophthalmol 183:25–36. https://doi.org/10.1016/j.ajo.2017.07.023 CrossRefPubMed

24.

Schlenker MB, Gulamhusein H, Conrad-Hengerer I, Somers A, Lenzhofer M, Stalmans I, Reitsamer H, Hengerer FH, Ahmed IIK (2017) Efficacy, safety, and risk factors for failure of standalone ab interno gelatin microstent implantation versus standalone trabeculectomy. Ophthalmology 124:1579–1588. https://doi.org/10.1016/j.ophtha.2017.05.004 CrossRefPubMed

25.

Ozal SA, Kaplaner O, Basar BB, Guclu H, Ozal E (2017) An innovation in glaucoma surgery: XEN45 gel stent implantation. Arq Bras Oftalmol 80:382–385. https://doi.org/10.5935/0004-2749.20170093 CrossRefPubMed

26.

Widder RA, Dietlein TS, Dinslage S, Kuhnrich P, Rennings C, Rossler G (2018) The XEN45 Gel Stent as a minimally invasive procedure in glaucoma surgery: success rates, risk profile, and rates of re-surgery after 261 surgeries. Graefes Arch Clin Exp Ophthalmol 256:765–771. https://doi.org/10.1007/s00417-018-3899-7 CrossRefPubMed

27.

Pérez-Torregrosa VT, Olate-Pérez A, Cerdà-Ibáñez M, Gargallo-Benedicto A, Osorio-Alayo V, Barreiro-Rego A, Duch-Samper A (2016) Combined phacoemulsification and XEN45 surgery from a temporal approach and 2 incisions. Arch Soc Esp Oftalmol 91:415–421. https://doi.org/10.1016/j.oftal.2016.02.006 CrossRefPubMed

28.

Fea AM, Spinetta R, Cannizzo PML, Consolandi G, Lavia C, Aragno V, Germinetti F, Rolle T (2017) Evaluation of bleb morphology and reduction in IOP and glaucoma medication following implantation of a novel gel stent. J Ophthalmol 2017:9364910. https://doi.org/10.1155/2017/9364910 CrossRefPubMedPubMedCentral

29.

Hohberger B, Welge-Lüßen UC, Lämmer R (2018) MIGS: therapeutic success of combined Xen Gel Stent implantation with cataract surgery. Graefes Arch Clin Exp Ophthalmol 256:621–625. https://doi.org/10.1007/s00417-017-3895-3

30.

Craven ER, Katz LJ, Wells JM, Giamporcaro JE (2012) Cataract surgery with trabecular micro-bypass stent implantation in patients with mild-to-moderate open-angle glaucoma and cataract: two-year follow-up. J Cataract Refract Surg 38:1339–1345. https://doi.org/10.1016/j.jcrs.2012.03.025 CrossRefPubMed

31.

Song BJ, Ramanathan M, Morales E, Law SK, Giaconi JA, Coleman AL, Caprioli J (2016) Trabeculectomy and combined phacoemulsification-trabeculectomy: outcomes and risk factors for failure in primary angle closure glaucoma. J Glaucoma 25:763–769. https://doi.org/10.1097/ijg.0000000000000493 CrossRefPubMedPubMedCentral

32.

Jung LJ, Isida-Llerandi CG, Lazcano-Gomez G, SooHoo JR, Kahook MY (2014) Intraocular pressure control after trabeculectomy, phacotrabeculectomy and phacoemulsification in a Hispanic population. J Curr Glaucoma Pract 8:67–74. https://doi.org/10.5005/jp-journals-10008-1164

33.

Murthy SK, Damji KF, Pan Y, Hodge WG (2006) Trabeculectomy and phacotrabeculectomy, with mitomycin-C, show similar two-year target IOP outcomes. Can J Ophthalmol 41:51–59. https://doi.org/10.1016/s0008-4182(06)80067-0 CrossRefPubMed

34.

Cillino S, Di Pace F, Casuccio A, Calvaruso L, Morreale D, Vadala M, Lodato G (2004) Deep sclerectomy versus punch trabeculectomy with or without phacoemulsification: a randomized clinical trial. J Glaucoma 13:500–506CrossRefPubMed

35.

Kuroda S, Mizoguchi T, Terauchi H, Nagata M (2001) Trabeculectomy combined with phacoemulsification and intraocular lens implantation. Semin Ophthalmol 16:168–171. https://doi.org/10.1076/soph.16.3.168.4203 CrossRefPubMed

36.

Guggenbach M, Mojon DS, Böhnke M (1999) Evaluation of phacotrabeculectomy versus trabeculectomy alone. Ophthalmologica 213:367–370. https://doi.org/10.1159/000027456 CrossRefPubMed

37.

Derick RJ, Evans J, Baker ND (1998) Combined phacoemulsification and trabeculectomy versus trabeculectomy alone: a comparison study using mitomycin-C. Ophthalmic Surg Lasers 29:707–713PubMed

38.

Yu CB, Chong NH, Caesar RH, Boodhoo MG, Condon RW (1996) Long-term results of combined cataract and glaucoma surgery versus trabeculectomy alone in low-risk patients. J Cataract Refract Surg 22:352–357CrossRefPubMed

39.

Chang TC, Budenz DL, Liu A, Kim WI, Dang T, Li C, Iwach AG, Radhakrishnan S, Singh K (2012) Long-term effect of phacoemulsification on intraocular pressure using phakic fellow eye as control. J Cataract Refract Surg 38:866–870. https://doi.org/10.1016/j.jcrs.2012.01.016 CrossRefPubMed

40.

Mansberger SL, Gordon MO, Jampel H, Bhorade A, Brandt JD, Wilson B, Kass MA (2012) Reduction in intraocular pressure after cataract extraction: the Ocular Hypertension Treatment Study. Ophthalmology 119:1826–1831. https://doi.org/10.1016/j.ophtha.2012.02.050 CrossRefPubMedPubMedCentral

41.

Slabaugh MA, Bojikian KD, Moore DB, Chen PP (2014) The effect of phacoemulsification on intraocular pressure in medically controlled open-angle glaucoma patients. Am J Ophthalmol 157:26–31. https://doi.org/10.1016/j.ajo.2013.08.023 CrossRefPubMed

42.

Gedde SJ, Herndon LW, Brandt JD, Budenz DL, Feuer WJ, Schiffman JC (2007) Surgical complications in the Tube Versus Trabeculectomy Study during the first year of follow-up. Am J Ophthalmol 143:23–31. https://doi.org/10.1016/j.ajo.2006.07.022 CrossRefPubMed

43.

Gedde SJ, Schiffman JC, Feuer WJ, Herndon LW, Brandt JD, Budenz DL (2009) Three-year follow-up of the Tube Versus Trabeculectomy Study. Am J Ophthalmol 148:670–684. https://doi.org/10.1016/j.ajo.2009.06.018 CrossRefPubMed

44.

Khouri SA, Huang G, Huang LY (2017) Intraoperative injection vs sponge-applied mitomycin C during trabeculectomy: one-year study. J Curr Glaucoma Pract 11:101–106. https://doi.org/10.5005/jp-journals-10028-1233 CrossRef

45.

Pakravan M, Esfandiari H, Yazdani S, Douzandeh A, Amouhashemi N, Yaseri M, Pakravan P (2017) Mitomycin C-augmented trabeculectomy: subtenon injection versus soaked sponges: a randomised clinical trial. Br J Ophthalmol 101:1275–1280. https://doi.org/10.1136/bjophthalmol-2016-309671 CrossRefPubMed

46.

Vera V, Ahmed IIK, Stalmans I, Reitsamer H (2018) Gel stent implantation—recommendations for preoperative assessment, surgical technique, and postoperative management. US Ophthalmic Rev 11:38–46. https://doi.org/10.17925/USOR.2018.11.1.38 CrossRef

47.

Vijaya L, Manish P, Ronnie G, Shantha B (2011) Management of complications in glaucoma surgery. Indian J Ophthalmol 59(Suppl):S131–S140. https://doi.org/10.4103/0301-4738.73689 CrossRefPubMedPubMedCentral

48.

Nguyen AH, Fatehi N, Romero P, Miraftabi A, Kim E, Morales E, Giaconi J, Coleman AL, Law SK, Caprioli J, Nouri-Mahdavi K (2018) Observational outcomes of initial trabeculectomy with mitomycin c in patients of African descent vs patients of European descent: five-year results. JAMA Ophthalmol 136:1106–1113. https://doi.org/10.1001/jamaophthalmol.2018.2897

49.

Tan C, Chew PT, Lum WL, Chee C (1996) Trabeculectomy—success rates in a Singapore hospital. Singap Med J 37:505–507

50.

Wong JS, Yip L, Tan C, Chew P (1998) Trabeculectomy survival with and without intra-operative 5-fluorouracil application in an Asian population. Aust N Z J Ophthalmol 26:283–288. https://doi.org/10.1111/j.1442-9071.1998.tb01331.x CrossRefPubMed

Title: Two-year results of a multicenter study of the ab interno gelatin implant in medically uncontrolled primary open-angle glaucoma
Authors: Herbert Reitsamer
Chelvin Sng
Vanessa Vera
Markus Lenzhofer
Keith Barton
Ingeborg Stalmans
For The Apex Study Group
Publication date: 01-05-2019
Publisher: Springer Berlin Heidelberg
Keywords: Glaucoma
Trabeculectomy
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 5/2019
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI: https://doi.org/10.1007/s00417-019-04251-z

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Two-year results of a multicenter study of the ab interno gelatin implant in medically uncontrolled primary open-angle glaucoma

Abstract

Purpose

Methods

Results

Conclusions

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 5/2019

Age-related differences in the prevalence of subtypes of Neovascular age-related macular degeneration in the first diagnosed eye

Peripapillary and macular morpho-vascular changes in patients with genetic or clinical diagnosis of autosomal dominant optic atrophy: a case-control study

Investigating retinal toxicity of a lutein-based dye in a model of isolated and perfused bovine retina

Increased soluble urokinase plasminogen activator receptor (suPAR) levels in neovascular age-related macular degeneration: a role for inflammation in the pathogenesis of the disease?

Idiopathic retinal vasculitis, aneurysms and neuroretinitis (IRVAN): case series of three patients with multimodal imaging

Dermatologic tacrolimus ointment on the eyelids for steroid-refractory vernal keratoconjunctivitis